Stocks and Investing Stocks and Investing
Tue, June 22, 2021
Mon, June 21, 2021

Gena Wang Downgraded (ARCT) to Sell and Decreased Target to $25 on, Jun 21st, 2021


Published on 2024-10-27 17:01:36 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Downgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Sell and Decreased Target from $33 to $25 on, Jun 21st, 2021.

Gena, nor any peers, have made any analyst calls on ARCT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources